Note 8 - Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Accrued Liabilities and Other Current Liabilities Disclosure [Text Block]

( 8 ) Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 31,
	2020		2019
Accrued expenses	$	87	$	10
Accrued salaries and employee benefits		961		652
Accrued director compensation		—		648
Accrued clinical trial costs		452		519
Grant liability		615		630
Customer deposits		90		102
Total	$	2,205	$	2,561